» Articles » PMID: 27393384

Self-nonself Discrimination by the Complement System

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2016 Jul 10
PMID 27393384
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

The alternative pathway (AP) of complement can recognize nonself structures by only two molecules, C3b and factor H. The AP deposits C3b covalently on nonself structures via an amplification system. The actual discrimination is performed by factor H, which has binding sites for polyanions (sialic acids, glycosaminoglycans, phospholipids). This robust recognition of 'self' protects our own intact viable cells and tissues, while activating structures are recognized by default. Foreign targets are opsonized for phagocytosis or killed. Mutations in factor H predispose to severe diseases. In hemolytic uremic syndrome, they promote complement attack against blood cells and vascular endothelial cells and lead, for example, to kidney and brain damage. Even pathogens can exploit factor H. In fact, the ability to bind factor H discriminates most pathogenic microbes from nonpathogenic ones.

Citing Articles

Understanding rare genetic variants within the terminal pathway of complement system in preeclampsia.

Lokki A, Triebwasser M, Daly E, Kurki M, Perola M, Auro K Genes Immun. 2024; 26(1):22-26.

PMID: 39690307 PMC: 11832413. DOI: 10.1038/s41435-024-00310-6.


Loss of function reduces the risk for age-related macular degeneration.

Reeve M, Loomis S, Nissila E, Rausch T, Zheng Z, Briotta Parolo P medRxiv. 2024; .

PMID: 39606340 PMC: 11601675. DOI: 10.1101/2024.11.11.24317117.


Complement therapeutic Factor H-IgG proteins as pre-exposure prophylaxes against Lyme borreliae infections.

McKaig C, Malfetano J, Tran Y, Yang X, Pal U, Wycoff K bioRxiv. 2024; .

PMID: 39386713 PMC: 11463399. DOI: 10.1101/2024.09.26.615144.


Factor H-related protein 1 in systemic lupus erythematosus.

Kleer J, Klehr J, Dubler D, Infanti L, Chizzolini C, Huynh-Do U Front Immunol. 2024; 15:1447991.

PMID: 39136026 PMC: 11317429. DOI: 10.3389/fimmu.2024.1447991.


Strategies to improve safety profile of AAV vectors.

Suoranta T, Laham-Karam N, Yla-Herttuala S Front Mol Med. 2024; 2:1054069.

PMID: 39086961 PMC: 11285686. DOI: 10.3389/fmmed.2022.1054069.